GlaxoSmithKline

Not verified. Claim this page

Visit Website

GlaxoSmithKline Sustainability Actions

Responsible business framework

GSK says responsible business is built into its strategy and culture. It groups its work into six focus areas: access, global health and health security, environment, inclusion, ethical standards, and product governance. In plain terms, this means the company says it tries to think about social, environmental, and governance issues while running the business, not as a side project. It also says this approach helps long-term performance, reduces risk, and supports trust with stakeholders.

3 8 12 13 16

Net zero and nature goals

GSK says it is working toward a net zero, nature positive, healthier planet, with ambitious goals for 2030 and 2045. Net zero means cutting greenhouse gas emissions as much as possible and balancing the rest. Nature positive means trying to improve the state of nature rather than just reduce harm. The company does not give full details in the material shown here, but it clearly treats environmental action as a major part of its responsible business plan.

13 15

Access to medicines

GSK says it aims to make its products available as widely as possible through responsible pricing, strategic access programmes, and partnerships. This is part of its access focus area. In simple terms, the company says it wants more people to be able to get the medicines and vaccines it makes, including in places where cost or supply can be a barrier.

3 10

Product governance and supply

GSK says product governance is one of its six focus areas and that it works to ensure the quality, safety, and reliable supply of its products. That means it says it has systems in place to help make sure medicines and vaccines are made and delivered in a controlled way. This is important in healthcare because poor quality or unstable supply can affect patient safety and access.

3 12

Inclusion and research

GSK says it wants to meet patients’ needs with research that includes people affected by the disease being studied, and it also says it wants to attract and keep talent from different backgrounds. In plain language, it is saying that research should reflect the people it is meant to help, and that the company wants a workforce where people can thrive regardless of background.

3 5 8 10

Australia reconciliation plan

GSK Australia says it has a Reconciliation Action Plan and wants an Australia that is united in its understanding and respect for Aboriginal and Torres Strait Islander peoples. A reconciliation plan is a formal company plan for improving relationships, respect, and opportunities for Indigenous communities. The page shown here does not give the full plan details, but it does show that GSK has made this a public responsibility area in Australia.

10 16

Greener operations and tech

A third-party article says GSK is using technology to support sustainability across its operations, including monitoring energy use, improving recycling processes, and reducing the carbon footprint of manufacturing. It also says the company is looking at greener inhaler propellants, which are the gases used to push medicine out of some inhalers. This is a useful sign that environmental work is not limited to offices and includes product and manufacturing choices.

9 12 13

New HQ sustainability design

A third-party article says GSK’s new London headquarters is planned with low-impact design and energy efficiency in mind. It also says the building aims for a top industry energy-efficiency rating and will include Europe’s first in-house vertical farm, which grows food in stacked indoor layers. The article presents this as part of GSK’s wider sustainability journey, though the details come from a press-style summary rather than an independent audit.

7 11 12 13

Nature and partnerships role

A GSK jobs page shows a role called Head of Nature and Partnerships. While this is not a sustainability report, it does suggest the company has dedicated work around nature and external partnerships. The page itself does not explain the full scope of the role, so it should be read as a sign of internal focus rather than proof of outcomes.

15 17

About GlaxoSmithKline

  • Status
  • Unverified